loadpatents
Patent applications and USPTO patent grants for Novira Therapeutics, Inc..The latest application filed is for "oxadiazepinone derivatives and methods of treating hepatitis b infections".
Patent | Date |
---|---|
Combinations and methods comprising a capsid assembly inhibitor Grant 11,129,834 - Hartman , et al. September 28, 2 | 2021-09-28 |
Oxadiazepinone Derivatives And Methods Of Treating Hepatitis B Infections App 20210252014 - Kuduk; Scott ;   et al. | 2021-08-19 |
Diazepinone Derivatives And Their Use In The Treatment Of Hepatitis B Infections App 20210188849 - Kuduk; Scott ;   et al. | 2021-06-24 |
Oxadiazepinone derivatives and methods of treating hepatitis B infections Grant 10,987,359 - Kuduk , et al. April 27, 2 | 2021-04-27 |
Diazepinone derivatives and their use in the treatment of hepatitis B infections Grant 10,975,077 - Kuduk , et al. April 13, 2 | 2021-04-13 |
Sulfide alkyl compounds for HBV treatment Grant 10,710,959 - Chen , et al. | 2020-07-14 |
Oxadiazepinone Derivatives And Methods Of Treating Hepatitis B Infections App 20200197408 - Kuduk; Scott ;   et al. | 2020-06-25 |
Derivatives And Methods Of Treating Hepatitis B Infections App 20200181142 - Hartman; George D. ;   et al. | 2020-06-11 |
Diazepinone Derivatives And Their Use In The Treatment Of Hepatitis B Infections App 20200181144 - Kuduk; Scott ;   et al. | 2020-06-11 |
Combination therapy for treatment of HBV infections Grant 10,632,112 - Hartman | 2020-04-28 |
Derivatives and methods of treating hepatitis B infections Grant 10,556,904 - Hartman , et al. Feb | 2020-02-11 |
Derivatives and methods of treating hepatitis B infections Grant 10,544,141 - Hartman , et al. Ja | 2020-01-28 |
Derivatives and methods of treating hepatitis B infections Grant 10,538,519 - Hartman , et al. Ja | 2020-01-21 |
Azocane and azonane derivatives and methods of treating hepatitis B infections Grant 10,537,580 - Hartman , et al. Ja | 2020-01-21 |
Combinations And Methods Comprising A Capsid Assembly Inhibitor App 20190365767 - Hartman; George ;   et al. | 2019-12-05 |
Combinations and methods comprising a capsid assembly inhibitor Grant 10,441,589 - Hartman , et al. Oc | 2019-10-15 |
Pyridyl reverse sulfonamides for HBV treatment Grant 10,428,041 - Clark , et al. October 1, 2 | 2019-10-01 |
Azepane derivatives and methods of treating hepatitis B infections Grant 10,392,349 - Hartman , et al. A | 2019-08-27 |
Metabolic Restriction In Cell-based Assays App 20190234940 - LAM; Man Iu ;   et al. | 2019-08-01 |
Azepane derivatives and methods of treating hepatitis B infections Grant 10,364,228 - Hartman | 2019-07-30 |
Combination Therapy For Treatment Of Hbv Infections App 20190209541 - Hartman; George D. | 2019-07-11 |
Sulfide Alkyl Compounds For Hbv Treatment App 20190202780 - Chen; Austin ;   et al. | 2019-07-04 |
Derivatives And Methods Of Treating Hepatitis B Infections App 20190194191 - Hartman; George D. ;   et al. | 2019-06-27 |
Pyridyl Reverse Sulfonamides For HBV Treatment App 20190152940 - Clark; Ryan C. ;   et al. | 2019-05-23 |
Derivatives And Methods Of Treating Hepatitis B Infections App 20190077800 - Hartman; George D. ;   et al. | 2019-03-14 |
Combination therapy for treatment of HBV infections Grant 10,213,420 - Hartman Feb | 2019-02-26 |
Hepatitis B antiviral agents Grant 10,196,376 - Hartman , et al. Fe | 2019-02-05 |
Sulfide alkyl compounds for HBV treatment Grant 10,196,351 - Chen , et al. Fe | 2019-02-05 |
Derivatives And Methods Of Treating Hepatitis B Infections App 20190031653 - Hartman; George D. ;   et al. | 2019-01-31 |
Derivatives and methods of treating hepatitis B infections Grant 10,189,835 - Hartman , et al. Ja | 2019-01-29 |
Azepane Derivatives And Methods Of Treating Hepatitis B Infections App 20190016682 - Hartman; George D. ;   et al. | 2019-01-17 |
Pyridyl reverse sulfonamides for HBV treatment Grant 10,160,742 - Clark , et al. Dec | 2018-12-25 |
Derivatives and methods of treating hepatitis B infections Grant 10,093,669 - Hartman , et al. October 9, 2 | 2018-10-09 |
Derivatives and methods of treating hepatitis B infections Grant 10,077,264 - Hartman , et al. September 18, 2 | 2018-09-18 |
Crystalline forms of a hepatitis B antiviral agent Grant 10,077,239 - Hartman September 18, 2 | 2018-09-18 |
Azocane And Azonane Derivatives And Methods Of Treating Hepatitis B Infections App 20180201590 - Hartman; George D. ;   et al. | 2018-07-19 |
Derivatives And Methods Of Treating Hepatitis B Infections App 20180127415 - Hartman; George D. ;   et al. | 2018-05-10 |
Pyridyl Reverse Sulfonamides For HBV Treatment App 20180051000 - Clark; Ryan C. ;   et al. | 2018-02-22 |
Azepane Derivatives And Methods Of Treating Hepatitis B Infections App 20180044300 - Hartman; George D. | 2018-02-15 |
Derivatives and methods of treating hepatitis B infections Grant 9,890,161 - Hartman , et al. February 13, 2 | 2018-02-13 |
Azocane and azonane derivatives and methods of treating hepatitis B infections Grant 9,884,831 - Hartman , et al. February 6, 2 | 2018-02-06 |
Azepane derivatives and methods of treating hepatitis B infections Grant 9,873,671 - Hartman , et al. January 23, 2 | 2018-01-23 |
Combinations And Methods Comprising A Capsid Assembly Inhibitor App 20170340642 - HARTMAN; George ;   et al. | 2017-11-30 |
Hepatitis B Antiviral Agents App 20170334882 - Hartman; George D. ;   et al. | 2017-11-23 |
Sulfide Alkyl Compounds For Hbv Treatment App 20170298014 - Chen; Austin ;   et al. | 2017-10-19 |
Pyridyl reverse sulfonamides for HBV treatment Grant 9,765,050 - Clark , et al. September 19, 2 | 2017-09-19 |
Azepane derivatives and methods of treating hepatitis B infections Grant 9,758,489 - Hartman September 12, 2 | 2017-09-12 |
Hepatitis B antiviral agents Grant 9,751,857 - Hartman , et al. September 5, 2 | 2017-09-05 |
Combination Therapy For Treatment Of Hbv Infections App 20170182021 - Hartman; George D. | 2017-06-29 |
Hepatitis B antiviral agents Grant 9,676,747 - Hartman , et al. June 13, 2 | 2017-06-13 |
Derivatives And Methods Of Treating Hepatitis B Infections App 20170158691 - Hartman; George D. ;   et al. | 2017-06-08 |
Derivatives And Methods Of Treating Hepatitis B Infections App 20170121329 - Hartman; George D. ;   et al. | 2017-05-04 |
Derivatives And Methods Of Treating Hepatitis B Infections App 20170121328 - Hartman; George D. ;   et al. | 2017-05-04 |
Crystalline Forms Of A Hepatitis B Antiviral Agent App 20170114018 - Hartman; George D. | 2017-04-27 |
Sulfide alkyl compounds for HBV treatment Grant 9,597,332 - Chen , et al. March 21, 2 | 2017-03-21 |
Hepatitis B antiviral agents Grant 9,579,313 - Hartman February 28, 2 | 2017-02-28 |
Derivatives and methods of treating hepatitis B infections Grant 9,550,779 - Hartman , et al. January 24, 2 | 2017-01-24 |
Azepane Derivatives And Methods Of Treating Hepatitis B Infections App 20170015629 - Hartman; George D. ;   et al. | 2017-01-19 |
Derivatives and methods of treating hepatitis B infections Grant 9,527,845 - Hartman , et al. December 27, 2 | 2016-12-27 |
Derivatives and methods of treating hepatitis B infections Grant 9,518,057 - Hartman , et al. December 13, 2 | 2016-12-13 |
Azepane derivatives and methods of treating hepatitis B infections Grant 9,505,722 - Hartman , et al. November 29, 2 | 2016-11-29 |
Azocane And Azonane Derivatives And Methods Of Treating Hepatitis B Infections App 20160272599 - Hartman; George D. ;   et al. | 2016-09-22 |
Piperidine derivatives and methods of treating hepatitis B infections Grant 9,400,280 - Hartman July 26, 2 | 2016-07-26 |
Derivatives And Methods Of Treating Hepatitis B Infections App 20160185778 - Hartman; George D. ;   et al. | 2016-06-30 |
Derivatives And Methods Of Treating Hepatitis B Infections App 20160185777 - Hartman; George D. ;   et al. | 2016-06-30 |
Derivatives And Methods Of Treating Hepatitis B Infections App 20160185779 - Hartman; George D. ;   et al. | 2016-06-30 |
Pyridyl Reverse Sulfonamides For Hbv Treatment App 20160185748 - Clark; Ryan C. ;   et al. | 2016-06-30 |
Hepatitis B Antiviral Agents App 20160158214 - Hartman; George D. | 2016-06-09 |
Sulfide Alkyl Compounds For Hbv Treatment App 20160151375 - Chen; Austin ;   et al. | 2016-06-02 |
Azepane derivatives and methods of treating hepatitis B infections Grant 9,339,510 - Hartman , et al. May 17, 2 | 2016-05-17 |
Azepane Derivatives And Methods Of Treating Hepatitis B Infections App 20160000812 - Hartman; George D. ;   et al. | 2016-01-07 |
Hepatitis B antiviral agents Grant 9,205,079 - Hartman December 8, 2 | 2015-12-08 |
Azepane derivatives and methods of treating hepatitis B infections Grant 9,181,288 - Hartman , et al. November 10, 2 | 2015-11-10 |
Azepane Derivatives And Methods Of Treating Hepatitis B Infections App 20150315159 - Hartman; George D. | 2015-11-05 |
Azepane derivatives and methods of treating hepatitis B infections Grant 9,169,212 - Hartman , et al. October 27, 2 | 2015-10-27 |
Piperidine Derivatives And Methods Of Treating Hepatitis B Infections App 20150274652 - Hartman; George D. | 2015-10-01 |
Hepatitis B Antiviral Agents App 20150259324 - Hartman; George D. ;   et al. | 2015-09-17 |
Azepane derivatives and methods of treating hepatitis B infections Grant 9,115,113 - Hartman August 25, 2 | 2015-08-25 |
Azepane Derivatives And Methods Of Treating Hepatitis B Infections App 20150225355 - Hartman; George D. | 2015-08-13 |
Combination Therapy For Treatment Of Hbv Infections App 20150216938 - Hartman; George D. | 2015-08-06 |
Azepane Derivatives And Methods Of Treating Hepatitis B Infections App 20150197533 - Hartman; George D. ;   et al. | 2015-07-16 |
Azepane Derivatives And Methods Of Treating Hepatitis B Infections App 20150197493 - Hartman; George D. | 2015-07-16 |
Hepatitis B antiviral agents Grant 9,066,932 - Hartman , et al. June 30, 2 | 2015-06-30 |
Hepatitis B Antiviral Agents App 20150174115 - Hartman; George D. | 2015-06-25 |
Hepatitis B antiviral agents Grant 9,061,008 - Hartman , et al. June 23, 2 | 2015-06-23 |
Hepatitis B Antiviral Agents App 20150152073 - Hartman; George D. ;   et al. | 2015-06-04 |
Azepane Derivatives And Methods Of Treating Hepatitis B Infections App 20150132258 - Hartman; George D. | 2015-05-14 |
Hepatitis B antiviral agents Grant 8,993,771 - Hartman March 31, 2 | 2015-03-31 |
Hepatitis B Antiviral Agents App 20140275167 - Hartman; George D. | 2014-09-18 |
Hepatitis B Antiviral Agents App 20140178337 - Hartman; George D. ;   et al. | 2014-06-26 |
Hepatitis B Antiviral Agents App 20140179665 - Hartman; George D. ;   et al. | 2014-06-26 |
Hepatitis B antiviral agents Grant 8,629,274 - Hartman , et al. January 14, 2 | 2014-01-14 |
Hepatitis B Antiviral Agents App 20130251673 - HARTMAN; George D. ;   et al. | 2013-09-26 |
NCAGE Code | 5FH88 | NOVIRA THERAPEUTICS INC. |
CAGE Code | 5FH88 | NOVIRA THERAPEUTICS INC. |
SEC | 0001556754 | Novira Therapeutics, Inc. of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.